Table: Delta-Fly Pharma -2021/22 parent results

Delta-Fly Pharma

13/05/2022 07:30

May 13 (Reuters)- 
          Delta-Fly Pharma, Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended        Year to         NEXT   
               Mar 31, 2022     Mar 31, 2021     Mar 31, 2023      YEAR     
                  LATEST          YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS          FORECAST     H1 FORECAST 
  Sales          300 mln          300 mln          300 mln                  
                (+0.0 pct)      (+200.0 pct)      (+0.0 pct)                
  Operating    loss 961 mln     loss 852 mln      loss 1.15                 
  Recurring    loss 964 mln     loss 859 mln      loss 1.15                 
  Net          loss 967 mln     loss 862 mln      loss 1.15                 
  EPS        loss 178.58 yen  loss 187.34 yen  loss 212.20 yen              
  Ann Div          NIL              NIL              NIL                    
  -Q2 Div          NIL              NIL              NIL                    
  -Q4 Div          NIL              NIL              NIL                    
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T